ARTICLE | Company News
UMN, API and Yakult in biosimilar deal
March 7, 2013 2:04 AM UTC
Yakult Honsha Co. Ltd. (Tokyo:2267), UMN Pharma Inc. (Tokyo:4585) and API Co. Ltd. (Gifu City, Japan) signed a letter of intent to co-develop and commercialize biosimilars of several undisclosed antib...